These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 19702477)

  • 1. Total estrogen time and obstructive coronary disease in women: insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE).
    Merz CN; Johnson BD; Berga SL; Braunstein GD; Azziz R; Yang Y; Reis SE; Bittner V; Hodgson TK; Pepine CJ; Sharaf BL; Sopko G; Kelsey SF;
    J Womens Health (Larchmt); 2009 Sep; 18(9):1315-22. PubMed ID: 19702477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Timing of hormone therapy, type of menopause, and coronary disease in women: data from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation.
    Shufelt CL; Johnson BD; Berga SL; Braunstein GD; Reis SE; Bittner V; Yang Y; Pepine CJ; Sharaf BL; Sopko G; Kelsey SF; Merz CN;
    Menopause; 2011 Sep; 18(9):943-50. PubMed ID: 21532511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoestrogenemia of hypothalamic origin and coronary artery disease in premenopausal women: a report from the NHLBI-sponsored WISE study.
    Bairey Merz CN; Johnson BD; Sharaf BL; Bittner V; Berga SL; Braunstein GD; Hodgson TK; Matthews KA; Pepine CJ; Reis SE; Reichek N; Rogers WJ; Pohost GM; Kelsey SF; Sopko G;
    J Am Coll Cardiol; 2003 Feb; 41(3):413-9. PubMed ID: 12575968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse outcomes among women presenting with signs and symptoms of ischemia and no obstructive coronary artery disease: findings from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) angiographic core laboratory.
    Sharaf B; Wood T; Shaw L; Johnson BD; Kelsey S; Anderson RD; Pepine CJ; Bairey Merz CN
    Am Heart J; 2013 Jul; 166(1):134-41. PubMed ID: 23816032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of physical fitness vs body mass index with coronary artery disease and cardiovascular events in women.
    Wessel TR; Arant CB; Olson MB; Johnson BD; Reis SE; Sharaf BL; Shaw LJ; Handberg E; Sopko G; Kelsey SF; Pepine CJ; Merz NB
    JAMA; 2004 Sep; 292(10):1179-87. PubMed ID: 15353530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ten-Year Mortality in the WISE Study (Women's Ischemia Syndrome Evaluation).
    Kenkre TS; Malhotra P; Johnson BD; Handberg EM; Thompson DV; Marroquin OC; Rogers WJ; Pepine CJ; Bairey Merz CN; Kelsey SF
    Circ Cardiovasc Qual Outcomes; 2017 Dec; 10(12):. PubMed ID: 29217675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detailed angiographic analysis of women with suspected ischemic chest pain (pilot phase data from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation [WISE] Study Angiographic Core Laboratory).
    Sharaf BL; Pepine CJ; Kerensky RA; Reis SE; Reichek N; Rogers WJ; Sopko G; Kelsey SF; Holubkov R; Olson M; Miele NJ; Williams DO; Merz CN;
    Am J Cardiol; 2001 Apr; 87(8):937-41; A3. PubMed ID: 11305981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of angiographic findings among postmenopausal women using unopposed estrogen, estrogen/progestin combinations, and nonusers.
    Husak L; Vaccarino V; Veledar E; Murrah N; Wenger NK
    Am J Cardiol; 2004 Mar; 93(5):563-8. PubMed ID: 14996580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women: a report from the Women's Ischemia Syndrome Evaluation.
    Marroquin OC; Kip KE; Kelley DE; Johnson BD; Shaw LJ; Bairey Merz CN; Sharaf BL; Pepine CJ; Sopko G; Reis SE;
    Circulation; 2004 Feb; 109(6):714-21. PubMed ID: 14970105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hostility scores are associated with increased risk of cardiovascular events in women undergoing coronary angiography: a report from the NHLBI-Sponsored WISE Study.
    Olson MB; Krantz DS; Kelsey SF; Pepine CJ; Sopko G; Handberg E; Rogers WJ; Gierach GL; McClure CK; Merz CN;
    Psychosom Med; 2005; 67(4):546-52. PubMed ID: 16046366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New evidence for cardiac benefit of postmenopausal hormone therapy.
    Mikkola TS; Savolainen-Peltonen H; Venetkoski M; Ylikorkala O
    Climacteric; 2017 Feb; 20(1):5-10. PubMed ID: 28042727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity distribution and reproductive hormone levels in women: a report from the NHLBI-sponsored WISE Study.
    Olson MB; Shaw LJ; Kaizar EE; Kelsey SF; Bittner V; Reis SE; Smith K; Braunstein GD; Berga SL; Johnson BD; Bairey Merz CN;
    J Womens Health (Larchmt); 2006 Sep; 15(7):836-42. PubMed ID: 16999639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sudden Cardiac Death in Women With Suspected Ischemic Heart Disease, Preserved Ejection Fraction, and No Obstructive Coronary Artery Disease: A Report From the Women's Ischemia Syndrome Evaluation Study.
    Mehta PK; Johnson BD; Kenkre TS; Eteiba W; Sharaf B; Pepine CJ; Reis SE; Rogers WJ; Kelsey SF; Thompson DV; Bittner V; Sopko G; Shaw LJ; Bairey Merz CN
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes mellitus, hypothalamic hypoestrogenemia, and coronary artery disease in premenopausal women (from the National Heart, Lung, and Blood Institute sponsored WISE study).
    Ahmed B; Bairey Merz CN; Johnson BD; Bittner V; Berga SL; Braunstein GD; Hodgson TK; Smith K; Shaw L; Kelsey SF; Sopko G;
    Am J Cardiol; 2008 Jul; 102(2):150-4. PubMed ID: 18602512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phytoestrogens and coronary microvascular function in women with suspected myocardial ischemia: a report from the Women's Ischemia Syndrome Evaluation (WISE) Study.
    Pepine CJ; von Mering GO; Kerensky RA; Johnson BD; McGorray SP; Kelsey SF; Pohost G; Rogers WJ; Reis SE; Sopko G; Bairey Merz CN;
    J Womens Health (Larchmt); 2007 May; 16(4):481-8. PubMed ID: 17521251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cystatin C levels on angiographic atherosclerosis progression and events among postmenopausal women with angiographically decompensated coronary artery disease (from the Women's Angiographic Vitamin and Estrogen [WAVE] study).
    Patel D; Ahmad S; Silverman A; Lindsay J
    Am J Cardiol; 2013 Jun; 111(12):1681-7. PubMed ID: 23499273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).
    Johnson BD; Kip KE; Marroquin OC; Ridker PM; Kelsey SF; Shaw LJ; Pepine CJ; Sharaf B; Bairey Merz CN; Sopko G; Olson MB; Reis SE;
    Circulation; 2004 Feb; 109(6):726-32. PubMed ID: 14970107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DHEA-S levels and cardiovascular disease mortality in postmenopausal women: results from the National Institutes of Health--National Heart, Lung, and Blood Institute (NHLBI)-sponsored Women's Ischemia Syndrome Evaluation (WISE).
    Shufelt C; Bretsky P; Almeida CM; Johnson BD; Shaw LJ; Azziz R; Braunstein GD; Pepine CJ; Bittner V; Vido DA; Stanczyk FZ; Bairey Merz CN
    J Clin Endocrinol Metab; 2010 Nov; 95(11):4985-92. PubMed ID: 20739385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipids and cardiovascular disease: do the findings and therapy apply equally to men and women?
    LaRosa JC
    Womens Health Issues; 1992; 2(2):102-11; discussion 111-3. PubMed ID: 1617306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project.
    Gulati M; Cooper-DeHoff RM; McClure C; Johnson BD; Shaw LJ; Handberg EM; Zineh I; Kelsey SF; Arnsdorf MF; Black HR; Pepine CJ; Merz CN
    Arch Intern Med; 2009 May; 169(9):843-50. PubMed ID: 19433695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.